Australia markets close in 19 minutes

The Hydration Pharmaceuticals Company Limited (HPC.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.00800.0000 (0.00%)
As of 03:38PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.81
52-week change 3-85.45%
S&P500 52-week change 323.20%
52-week high 30.0600
52-week low 30.0080
50-day moving average 30.0273
200-day moving average 30.0273

Share statistics

Avg vol (3-month) 337.44k
Avg vol (10-day) 332.99k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8174.41M
% held by insiders 126.64%
% held by institutions 135.69%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -80.69%
Operating margin (ttm)-79.15%

Management effectiveness

Return on assets (ttm)-56.65%
Return on equity (ttm)-447.28%

Income statement

Revenue (ttm)10.04M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-4.70%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-8.1M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.84M
Total cash per share (mrq)0.01
Total debt (mrq)3.89M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.13
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-5.73M
Levered free cash flow (ttm)-2.9M